Visiopharm® is a world leader in Augmented Pathology™ solutions; that comprise precision pathology and high-throughput pathology for tissue-diagnostics and research. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and diagnostic pathology labs all over the world utilize the Oncotopix® platform for tissue-based research and diagnostics. The newest advancements in artificial intelligence and deep learning further consolidates Oncotopix® as the most comprehensive and highly configurable solution for tissue analysis on the market today. Our solutions are featured in over 1300 peer-reviewed scientific publications compatible with leading slide scanner manufacturers and data management software. Visiopharm® is certified according to EN ISO 13485:2016, covering design, development, manufacture, installation, and service of in vitro diagnostics pathology software.